Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Lamictal TM, Haloperidol Decanoate in Schizophrenia (CMCOBaku)

This study has been terminated.
(All of the mentioned aim and objectives were achieved before the February 2007)
Sponsor:
Information provided by:
Central Mental Clinic for Outpatients of Baku City
ClinicalTrials.gov Identifier:
NCT00947375
First received: July 20, 2009
Last updated: July 27, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2007
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)